Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Channel increases dividend, mulls ASX listing
Infrastructure

Channel increases dividend, mulls ASX listing

Dividend up from 11c to between 12c and 12.5c. 

Ian Llewellyn 23 May 2025
The elephant in the room
Policy Opinion

Katrina Van Houtte: The elephant in the room

Budget 2025: Cross-parliamentary consensus is needed for infrastructure projects to flow. 

Budget 2025: 'No big bang' for infrastructure
Infrastructure

Budget 2025: 'No big bang' for infrastructure

Only one of three non-roading PPPs got funding in the Budget.

Oliver Lewis 23 May 2025
Euro Corp earnings crash as demand contracts
Infrastructure

Euro Corp earnings crash as demand contracts

The steel maker has been bashed by Trump tariffs and ongoing uncertainty.

Victoria Young 22 May 2025